litlas
ログインアカウント作成

W. Douglas Weaver

1977–2025 年に発表

別表記
W.Douglas Weaver · W Douglas Weaver · W. DOUGLAS WEAVER
96
論文数
21,745
被引用数
86
h 指数
96
i10 指数

被引用数

W. Douglas Weaver の年別被引用数1944 年: 被引用 1 件1977 年: 被引用 1 件1978 年: 被引用 1 件1979 年: 被引用 7 件1981 年: 被引用 1 件1982 年: 被引用 4 件1983 年: 被引用 2 件1984 年: 被引用 6 件1985 年: 被引用 1 件1986 年: 被引用 8 件1987 年: 被引用 1 件1988 年: 被引用 11 件1989 年: 被引用 10 件1990 年: 被引用 34 件1991 年: 被引用 28 件1992 年: 被引用 20 件1993 年: 被引用 43 件1994 年: 被引用 49 件1995 年: 被引用 69 件1996 年: 被引用 99 件1997 年: 被引用 129 件1998 年: 被引用 170 件1999 年: 被引用 133 件2000 年: 被引用 192 件2001 年: 被引用 182 件2002 年: 被引用 145 件2003 年: 被引用 205 件2004 年: 被引用 199 件2005 年: 被引用 198 件2006 年: 被引用 173 件2007 年: 被引用 152 件2008 年: 被引用 120 件2009 年: 被引用 113 件2010 年: 被引用 157 件2011 年: 被引用 122 件2012 年: 被引用 108 件2013 年: 被引用 118 件2014 年: 被引用 108 件2015 年: 被引用 111 件2016 年: 被引用 101 件2017 年: 被引用 87 件2018 年: 被引用 84 件2019 年: 被引用 227 件2020 年: 被引用 250 件2021 年: 被引用 200 件2022 年: 被引用 133 件2023 年: 被引用 96 件2024 年: 被引用 148 件2025 年: 被引用 87 件2026 年: 被引用 6 件1945〜1976 年は被引用が無いため表示していません1980 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,979 件、この内訳の 33.4%イギリス: 引用元論文 493 件、この内訳の 8.3%カナダ: 引用元論文 318 件、この内訳の 5.4%ドイツ: 引用元論文 284 件、この内訳の 4.8%イタリア: 引用元論文 274 件、この内訳の 4.6%オランダ: 引用元論文 222 件、この内訳の 3.7%フランス: 引用元論文 197 件、この内訳の 3.3%中国: 引用元論文 188 件、この内訳の 3.2%オーストラリア: 引用元論文 178 件、この内訳の 3%スペイン: 引用元論文 157 件、この内訳の 2.7%スウェーデン: 引用元論文 150 件、この内訳の 2.5%日本: 引用元論文 116 件、この内訳の 2%
0%33.4%その他 23.1%

機関

分野

  • Medicine82.3%
  • Biochemistry, Genetics and Molecular Biology6.2%
  • Immunology and Microbiology3.1%
  • Engineering1.8%
  • Economics, Econometrics and Finance1.4%
  • Health Professions1.4%
  • その他3.8%

トピック

  • Acute Myocardial Infarction Research11.9%
  • Cardiac Imaging and Diagnostics4.9%
  • Cardiac Arrest and Resuscitation4.8%
  • Coronary Interventions and Diagnostics4.4%
  • Heart Failure Treatment and Management2.9%
  • Antiplatelet Therapy and Cardiovascular Diseases2.7%
  • その他68.4%

共著者

全論文

検索で開く
  1. Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome

    著者: Michelle L. O’Donoghue, Eugene Braunwald, Harvey D. White, Dylan P. Steen, Mary Ann Lukas, Elizabeth Tarka, Philippe Gabríel Steg, Judith S. Hochman, Christoph Bode, Aldo P. Maggioni, KyungAh Im, Jennifer B. Shannon, Richard Y. Davies, Sabina A. Murphy, Sharon Crugnale, Stephen D. Wiviott, Marc P. Bonaca, David F. Watson, W. Douglas Weaver, Patrick W. Serruys, Christopher P. Cannon - JAMA 2014 被引用: 456

  2. EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention

    著者: C. Michael Gibson, Robert P. Giugliano, Robert A. Kloner, Christoph Bode, Michał Tendera, András Jánosi, Béla Merkely, Jacek Godlewski, Rim Halaby, Serge Korjian, Yazan Daaboul, Anjan Chakrabarti, Kathryn Spielman, Brandon J Neal, W. Douglas Weaver - European Heart Journal 2015 被引用: 155

  3. Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

    著者: Claes Held, Harvey D. White, Ralph Stewart, Andrzej Budaj, Christopher P. Cannon, Judith S. Hochman, Wolfgang Köenig, Agneta Siegbahn, Philippe Gabríel Steg, Joseph Soffer, W. Douglas Weaver, Ollie Östlund, Lars Wallentin, on behalf of the STABILITY Investigators - Journal of the American Heart Association 2017 被引用: 281

  4. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy

    著者: Amel Karaa, Richard Haas, Amy Goldstein, Jerry Vockley, W. Douglas Weaver, Bruce H. Cohen - Neurology 2018 被引用: 148

  5. Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

    著者: Christopher B. Granger, Kenneth W. Mahaffey, W. Douglas Weaver, Pierre Théroux, Judith S. Hochman, Thomas G. Filloon, Scott A. Rollins, Thomas G. Todaro, José Carlos Nicolau, Witold Rużyłło, Paul W. Armstrong - Circulation 2003 被引用: 320

  6. Misdiagnosis of atrial fibrillation and its clinical consequences

    著者: Frank Bogun, Daejoon Anh, Gautham Kalahasty, Erik Wißner, Chadi Bou Serhal, Rabih Bazzi, W. Douglas Weaver, Claudio Schuger - The American Journal of Medicine 2004 被引用: 167

  7. Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction

    著者: Kerry L. Lee, Lynn H. Woodlief, Eric J. Topol, W. Douglas Weaver, Amadeo Betriu, Jacques Col, Maarten L. Simoons, Philip E. Aylward, Frans Van de Werf, Robert M. Califf - Circulation 1995 被引用: 1,093

  8. Acute Coronary Care in the Elderly, Part I

    著者: Karen P. Alexander, L. Kristin Newby, Christopher P. Cannon, Paul W. Armstrong, W. Brian Gibler, Michael W. Rich, Frans Van de Werf, Harvey D. White, W. Douglas Weaver, Mary D. Naylor, Joel M. Gore, Harlan M. Krumholz, E. Magnus Ohman - Circulation 2007 被引用: 912

  9. Effects of Selective Matrix Metalloproteinase Inhibitor (PG-116800) to Prevent Ventricular Remodeling After Myocardial Infarction

    著者: Michael Hudson, Paul W. Armstrong, Witold Rużyłło, José M. Brum, Lisa Cusmano, Piotr Krzeski, Robert A. Lyon, Miguel A. Quiñones, Pierre Théroux, Diana Sydlowski, Henry E. Kim, Mario J. García, Wael A. Jaber, W. Douglas Weaver - Journal of the American College of Cardiology 2006 被引用: 210

  10. Acute Coronary Care in the Elderly, Part II

    著者: Karen P. Alexander, L. Kristin Newby, Paul W. Armstrong, Christopher P. Cannon, W. Brian Gibler, Michael W. Rich, Frans Van de Werf, Harvey D. White, W. Douglas Weaver, Mary D. Naylor, Joel M. Gore, Harlan M. Krumholz, E. Magnus Ohman - Circulation 2007 被引用: 482

  11. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention

    著者: Philippe Gabríel Steg, Stefan James, Robert A. Harrington, Diego Ardissino, Richard C. Becker, Christopher P. Cannon, Håkan Emanuelsson, Ariel Finkelstein, Steen Husted, Hugo Katus, Jan Kilhamn, Sylvia Olofsson, Robert F. Storey, W. Douglas Weaver, Lars Wallentin, for the PLATO Study Group - Circulation 2010 被引用: 504

  12. ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction:Executive Summary

    著者: Thomas J. Ryan, Jeffrey L. Anderson, Elliott M. Antman, Blaine A. Braniff, Neil Brooks, Robert M. Califf, L. David Hillis, Loren F. Hiratzka, Elliot Rapaport, Bárbara Riegel, Richard O. Russell, Earl E. Smith, W. Douglas Weaver - Circulation 1996 被引用: 305

  13. Comparison of Clinical Interpretation With Visual Assessment and Quantitative Coronary Angiography in Patients Undergoing Percutaneous Coronary Intervention in Contemporary Practice

    著者: Brahmajee K. Nallamothu, John A. Spertus, Alexandra J. Lansky, David J. Cohen, Philip G. Jones, Faraz Kureshi, Gregory Dehmer, Joseph P. Drozda, Mary Norine Walsh, John E. Brush, Gerald Koenig, Thad F. Waites, D. Scott Gantt, George Kichura, Richard A. Chazal, Peter K. O’Brien, C. Michael Valentine, John S. Rumsfeld, Johan H. C. Reiber, Joann G. Elmore, Richard A. Krumholz, W. Douglas Weaver, Harlan M. Krumholz - Circulation 2013 被引用: 152

  14. Multicenter, Randomized, Controlled Trial of 150-J Biphasic Shocks Compared With 200- to 360-J Monophasic Shocks in the Resuscitation of Out-of-Hospital Cardiac Arrest Victims

    著者: Thomas Schneider, Patrick Martens, H.-R. Paschen, Markku Kuisma, Benno Wolcke, Bradford E. Gliner, James K. Russell, W. Douglas Weaver, Leo Bossaert, Douglas Chamberlain - Circulation 2000 被引用: 331

  15. Interleukin‐18 in patients with acute coronary syndromes

    著者: Axel Åkerblom, Stefan James, Tatevik Ghukasyan Lakic, Richard C. Becker, Christopher P. Cannon, Philippe Gabríel Steg, Anders Himmelmänn, Hugo A. Katus, Robert F. Storey, Lars Wallentin, W. Douglas Weaver, Agneta Siegbahn, on behalf of the PLATO Investigators - Clinical Cardiology 2019 被引用: 31

  16. TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction

    著者: Christopher P. Cannon, C. Michael Gibson, Carolyn H. McCabe, A.A.J. Adgey, Marc J. Schweiger, Rafael F. Sequeira, Gilles Grollier, Robert P. Giugliano, Martin J. Frey, Hiltrud S. Mueller, Richard M. Steingart, W. Douglas Weaver, Frans Van de Werf, Eugene Braunwald - Circulation 1998 被引用: 356

  17. Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction

    著者: Kenneth W. Mahaffey, Christopher B. Granger, José Carlos Nicolau, Witold Rużyłło, W. Douglas Weaver, Pierre Théroux, Judith S. Hochman, Thomas G. Filloon, Christopher F. Mojcik, Thomas G. Todaro, Paul W. Armstrong - Circulation 2003 被引用: 176

  18. Use of Reperfusion Therapy for Acute Myocardial Infarction in the United States

    著者: Hal V. Barron, Laura J. Bowlby, Tim Breen, William J. Rogers, John G. Canto, Yuan Zhang, Alan J. Tiefenbrunn, W. Douglas Weaver - Circulation 1998 被引用: 318

  19. The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention

    著者: Issam Moussa, Anthony Hermann, John C. Messenger, Gregory Dehmer, W. Douglas Weaver, John S. Rumsfeld, Frederick A. Masoudi - Heart 2013 被引用: 132

  20. Factors influencing survival after out-of-hospital cardiac arrest

    著者: W. Douglas Weaver, Leonard A. Cobb, Alfred P. Hallstrom, Carol Fahrenbruch, Michael K. Copass, Roberta M. Ray - Journal of the American College of Cardiology 1986 被引用: 325

  21. Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I

    著者: James McCord, Richard M. Nowak, Peter A. McCullough, Craig C. Foreback, Steven Borzak, Glenn Tokarski, Michael C. Tomlanovich, Gordon Jacobsen, W. Douglas Weaver - Circulation 2001 被引用: 302

  22. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006

    著者: C. Michael Gibson, Yuri B. Pride, Paul D. Frederick, Charles V. Pollack, John G. Canto, Alan J. Tiefenbrunn, W. Douglas Weaver, Costas T. Lambrew, William J. French, Eric D. Peterson, William J. Rogers - American Heart Journal 2008 被引用: 280

  23. Enhanced Mortality Risk Prediction With a Focus on High-Risk Percutaneous Coronary Intervention

    著者: James M. Brennan, Jeptha P. Curtis, David Dai, Susan Fitzgerald, Akshay Khandelwal, John A. Spertus, Sunil V. Rao, Mandeep Singh, Richard E. Shaw, Kalon K.L. Ho, Ronald J. Krone, William S. Weintraub, W. Douglas Weaver, Eric D. Peterson - JACC: Cardiovascular Interventions 2013 被引用: 187

  24. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study

    著者: Peter A. McCullough, Edward F. Philbin, John A. Spertus, Scott Kaatz, Keisha R. Sandberg, W. Douglas Weaver - Journal of the American College of Cardiology 2002 被引用: 552